Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

First platform trial for ALS hopes to accelerate the development of effective treatments

A new paper in Annals of Neurology describes the approach, structure, and launch of the HEALEY ALS Platform Trial– the first platform trial for amyotrophic lateral sclerosis (ALS) designed to accelerate the development of effective and breakthrough treatments for people with the illness.

28 Feb 2022

Breakthrough SARS-CoV-2 infection peaks at 5 months

A new study describes the incidence of breakthrough infection with SARS-CoV-2 after vaccination with one of the nucleic acid or viral vector vaccines.

28 Feb 2022

Comprehensive approach may promote Advance Care Planning for elderly adults

New research, published in JAMA Network Open shows that using a comprehensive approach to engage patients in Advance Care Planning (ACP) during the COVID-19 pandemic effectively improves the opportunity for ACP discussions and documentation as well as equitable healthcare delivery.

28 Feb 2022

Scientists investigate the antiviral properties of cow milk protein against SARS-CoV-2 variants

As the COVID-19 pandemic continues to claim lives around the world, dairy scientists may have a surprising role to play. In a new report published in the Journal of Dairy Science, scientists from the University of Michigan (Ann Arbor, MI, USA) and Glanbia PLC Research and Development (Twin Falls, ID, USA) have collaborated to investigate the antiviral properties of cow milk protein against variants of SARS-CoV-2, the virus behind the illness.

28 Feb 2022

Study shows the impact of gender-affirming hormone therapy on epigenetic signature of genes

Gender-affirming hormone therapy could influence the way a person's genes are turned on or off, according to a new study.

28 Feb 2022

Researchers create model to explore SARS-CoV-2 Omicron and Delta supremacy

In a new study, researchers have created a model to help identify the dynamics of Delta and Omicron infection in the US, as well as explore the effects of various factors on the overall COVID-19 pandemic.

28 Feb 2022

New CDC reports provide insights on the health and well-being of children during the pandemic

Today, CDC is releasing two new reports in MMWR that provide important insights on the health and well-being of children and adolescents during the COVID-19 pandemic.

28 Feb 2022

Assessing COVID-19 vaccination preferences of younger adults in Canada

A new study investigated the preferences of younger Canadian adults towards COVID-19 vaccination.

28 Feb 2022

COVID-19 provided an opportunity to promote handwashing in South Asia

Nicolas Osbert is convinced that when it comes to promoting the concept of handwashing, two years of the COVID-19 pandemic achieved what UNICEF, WHO and development agencies could not in two decades.

28 Feb 2022

Histopathologic and molecular effects in the placenta after SARS-CoV-2 infection during pregnancy

A recent study evaluated the molecular and histopathological effects in the placenta following a SARS-CoV-2 infection during pregnancy.

28 Feb 2022

Immunity before and after the SARS-CoV-2 Omicron variant in South Africa

Researchers conducted a national epidemiological survey to determine the seropositivity against SARS-CoV-2 before the emergence of the novel Omicron variant of concern.

28 Feb 2022

ESMO announces a new series of resources to guide physicians in oncological practice

ESMO, the leading professional organization for medical oncology, announces a new series of resources designed to guide physicians in areas of oncological practice not covered by guidelines, where current evidence is insufficient to evenly inform clinical decision-making.

28 Feb 2022

Antibody prevalence found to be highest among secondary school students in England

Over three quarters of secondary school pupils and nearly half of primary schools pupils are estimated to have had antibodies against COVID-19 in December last year, according to new data from the Schools Infection Survey (SIS).

28 Feb 2022

Distributed lag models to estimate incident rates using concentrations of SARS-CoV-2 RNA from wastewater solids

The team analyzed the effect of sampling frequency on the prediction error of IRs by using reduced sampling across different sewer sheds of varying sizes and features.

28 Feb 2022

Health events amongst pregnant females after COVID-19 vaccination

Researchers evidenced that mRNA-based COVID-19 vaccines are safe in pregnancy, with lower rates of significant AEFIs in pregnant women than non-pregnant females.

28 Feb 2022

The need for a holistic and unbiased approach to develop a more universal vaccine for coronaviruses

Researchers emphasized the need to take on a holistic and unbiased approach to develop a universal vaccine for coronaviruses, including SARS-CoV-2, which is a biomedical priority during the ongoing COVID-19 pandemic.

28 Feb 2022

From Alabama to Utah, efforts to vaccinate Medicaid enrollees against covid run into obstacles

Medicaid enrollees continue to get vaccinated against covid at far lower rates than the general population despite vigorous outreach efforts by government officials and private organizations to get low-income people inoculated, according to data from several states.

28 Feb 2022

Noncovalent protease inhibitors against SARS-CoV-2 and other coronaviruses

In a new study published in ACS Infectious Diseases journal, scientists biochemically and structurally evaluated the PLpro from a subgroup 2b bat coronavirus, BtSCoV-Rf1.2004, to identify unique structural features or enzymatic biases of the subgroup 2b.

28 Feb 2022

No seroprevalence observed against SARS-CoV-2 in wild ruminants in Germany

A team of scientists from Germany has recently conducted a serological screening on wild animals to assess seroprevalence against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and other pathogenic viruses related to domestic ruminants.

27 Feb 2022

Will Omicron BA.2 become the next dominant variant?

A new study presents a comprehensive analysis of the potential of both Omicron BA.2 and BA.3 to become the next dominant circulating SARS-CoV-2 strain.

27 Feb 2022

Pandemic News and Research

Further Reading

First platform trial for ALS hopes to accelerate the development of effective treatments

Breakthrough SARS-CoV-2 infection peaks at 5 months

Comprehensive approach may promote Advance Care Planning for elderly adults

Scientists investigate the antiviral properties of cow milk protein against SARS-CoV-2 variants

Study shows the impact of gender-affirming hormone therapy on epigenetic signature of genes

Researchers create model to explore SARS-CoV-2 Omicron and Delta supremacy

New CDC reports provide insights on the health and well-being of children during the pandemic

Assessing COVID-19 vaccination preferences of younger adults in Canada

COVID-19 provided an opportunity to promote handwashing in South Asia

Histopathologic and molecular effects in the placenta after SARS-CoV-2 infection during pregnancy

Immunity before and after the SARS-CoV-2 Omicron variant in South Africa

ESMO announces a new series of resources to guide physicians in oncological practice

Antibody prevalence found to be highest among secondary school students in England

Distributed lag models to estimate incident rates using concentrations of SARS-CoV-2 RNA from wastewater solids

Health events amongst pregnant females after COVID-19 vaccination

The need for a holistic and unbiased approach to develop a more universal vaccine for coronaviruses

From Alabama to Utah, efforts to vaccinate Medicaid enrollees against covid run into obstacles

Noncovalent protease inhibitors against SARS-CoV-2 and other coronaviruses

No seroprevalence observed against SARS-CoV-2 in wild ruminants in Germany

Will Omicron BA.2 become the next dominant variant?

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News